Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | HCRTR1 | O43613 | 14/20 | 0.51 |
| ▸ | HCRTR2 | O43614 | 13/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.43 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.43 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TNF | P01375 | 1/20 | 0.41 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.41 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5243815 | 0.86 | ALDH1A1 (0.52) | ALDH1A1HCRTR1HCRTR2TSHRLMNA | |
| SCHEMBL5240643 | 0.84 | ALDH1A1 (0.50) | ALDH1A1HCRTR1HCRTR2TSHRLMNA | |
| SCHEMBL5243101 | 0.80 | ABCB1 (0.44) | ALDH1A1LMNAABCB1ABCC1ABCG2 | |
| SCHEMBL2028806 | 0.78 | HCRTR1 (0.53) | ALDH1A1HCRTR1HCRTR2CYP3A4 | |
| SCHEMBL4601808 | 0.77 | ABCB1 (0.48) | ALDH1A1LMNAABCB1ABCC1ABCG2 | |
| SCHEMBL5243418 | 0.77 | ALDH1A1 (0.50) | ALDH1A1TSHRLMNATNFNOD2 | |
| SCHEMBL5241430 | 0.76 | ALDH1A1 (0.52) | ALDH1A1TSHRLMNATNFNOD2 | |
| SCHEMBL5243392 | 0.75 | ABCB1 (0.46) | ALDH1A1LMNAABCB1ABCC1ABCG2 | |
| SCHEMBL5240721 | 0.75 | ALDH1A1 (0.50) | ALDH1A1HCRTR1HCRTR2TSHRLMNA | |
| SCHEMBL2056301 | 0.74 | ALDH1A1 (0.58) | ALDH1A1HCRTR1HCRTR2TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1778634-A1 | ISOINDOLONE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS | AstraZeneca AB (SE) | 2007-05-02 | — | — | EP | disclosed |
| WO-2006020879-A1 | ISOINDOLONE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS | ASTRAZENECA AB (SE) | 2006-02-23 | — | — | WO | disclosed |